1. Home
  2. XOMA vs NBH Comparison

XOMA vs NBH Comparison

Compare XOMA & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • NBH
  • Stock Information
  • Founded
  • XOMA 1981
  • NBH 2002
  • Country
  • XOMA United States
  • NBH United States
  • Employees
  • XOMA N/A
  • NBH N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • NBH Finance/Investors Services
  • Sector
  • XOMA Health Care
  • NBH Finance
  • Exchange
  • XOMA Nasdaq
  • NBH Nasdaq
  • Market Cap
  • XOMA 320.8M
  • NBH 328.2M
  • IPO Year
  • XOMA N/A
  • NBH N/A
  • Fundamental
  • Price
  • XOMA $28.59
  • NBH $11.03
  • Analyst Decision
  • XOMA Strong Buy
  • NBH
  • Analyst Count
  • XOMA 2
  • NBH 0
  • Target Price
  • XOMA $78.50
  • NBH N/A
  • AVG Volume (30 Days)
  • XOMA 18.9K
  • NBH 85.9K
  • Earning Date
  • XOMA 11-05-2024
  • NBH 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • NBH 4.34%
  • EPS Growth
  • XOMA N/A
  • NBH N/A
  • EPS
  • XOMA N/A
  • NBH 0.12
  • Revenue
  • XOMA $15,239,000.00
  • NBH N/A
  • Revenue This Year
  • XOMA $456.45
  • NBH N/A
  • Revenue Next Year
  • XOMA $29.84
  • NBH N/A
  • P/E Ratio
  • XOMA N/A
  • NBH $87.04
  • Revenue Growth
  • XOMA 277.95
  • NBH N/A
  • 52 Week Low
  • XOMA $14.27
  • NBH $8.75
  • 52 Week High
  • XOMA $30.50
  • NBH $11.01
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 53.55
  • NBH 45.73
  • Support Level
  • XOMA $28.66
  • NBH $11.06
  • Resistance Level
  • XOMA $30.50
  • NBH $11.17
  • Average True Range (ATR)
  • XOMA 1.07
  • NBH 0.08
  • MACD
  • XOMA 0.21
  • NBH -0.01
  • Stochastic Oscillator
  • XOMA 55.56
  • NBH 33.86

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About NBH Neuberger Berman Municipal Fund Inc.

Neuberger Berman Intermediate Muni Fund is a closed-end management investment company that invests mainly in municipal securities. It aims to provide common stockholders a high level of current income exempt from Federal income tax.

Share on Social Networks: